X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs DIVIS LABORATORIES - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA DIVIS LABORATORIES SANOFI INDIA/
DIVIS LABORATORIES
 
P/E (TTM) x 35.7 31.3 114.2% View Chart
P/BV x 6.3 7.1 88.7% View Chart
Dividend Yield % 1.4 0.6 219.0%  

Financials

 SANOFI INDIA   DIVIS LABORATORIES
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
DIVIS LABORATORIES
Mar-18
SANOFI INDIA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs6,8401,142 599.1%   
Low Rs4,630533 868.5%   
Sales per share (Unadj.) Rs1,203.1146.6 820.7%  
Earnings per share (Unadj.) Rs165.333.0 500.2%  
Cash flow per share (Unadj.) Rs209.938.4 546.5%  
Dividends per share (Unadj.) Rs84.0010.00 840.0%  
Dividend yield (eoy) %1.51.2 122.7%  
Book value per share (Unadj.) Rs963.6222.8 432.4%  
Shares outstanding (eoy) m23.03265.47 8.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.85.7 83.4%   
Avg P/E ratio x34.725.3 136.9%  
P/CF ratio (eoy) x27.321.8 125.3%  
Price / Book Value ratio x6.03.8 158.4%  
Dividend payout %50.830.3 167.9%   
Avg Mkt Cap Rs m132,078222,318 59.4%   
No. of employees `0003.310.8 30.7%   
Total wages/salary Rs m4,0684,561 89.2%   
Avg. sales/employee Rs Th8,393.83,616.0 232.1%   
Avg. wages/employee Rs Th1,232.4423.8 290.8%   
Avg. net profit/employee Rs Th1,153.0814.9 141.5%   
INCOME DATA
Net Sales Rs m27,70838,915 71.2%  
Other income Rs m8971,134 79.1%   
Total revenues Rs m28,60540,049 71.4%   
Gross profit Rs m6,23512,617 49.4%  
Depreciation Rs m1,0271,425 72.1%   
Interest Rs m713 52.6%   
Profit before tax Rs m6,09812,313 49.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2923,543 64.7%   
Profit after tax Rs m3,8068,770 43.4%  
Gross profit margin %22.532.4 69.4%  
Effective tax rate %37.628.8 130.6%   
Net profit margin %13.722.5 61.0%  
BALANCE SHEET DATA
Current assets Rs m15,92245,351 35.1%   
Current liabilities Rs m6,2356,507 95.8%   
Net working cap to sales %35.099.8 35.0%  
Current ratio x2.67.0 36.6%  
Inventory Days Days64127 50.2%  
Debtors Days Days2195 21.9%  
Net fixed assets Rs m7,53921,160 35.6%   
Share capital Rs m230531 43.3%   
"Free" reserves Rs m21,96258,625 37.5%   
Net worth Rs m22,19259,156 37.5%   
Long term debt Rs m00-   
Total assets Rs m29,83967,832 44.0%  
Interest coverage x872.1926.8 94.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 161.9%   
Return on assets %12.812.9 98.7%  
Return on equity %17.214.8 115.7%  
Return on capital %27.520.8 132.0%  
Exports to sales %00-   
Imports to sales %021.8 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA8,485 0.0%   
Fx inflow Rs m7,58732,359 23.4%   
Fx outflow Rs m7,1459,042 79.0%   
Net fx Rs m44223,317 1.9%   
CASH FLOW
From Operations Rs m3,7397,759 48.2%  
From Investments Rs m-731-4,783 15.3%  
From Financial Activity Rs m-1,972-3,142 62.8%  
Net Cashflow Rs m1,036-166 -624.1%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 11.8 122.0%  
FIIs % 14.6 19.0 76.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 17.2 61.0%  
Shareholders   15,184 31,796 47.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   ALKEM LABORATORIES  PLETHICO PHARMA  GLENMARK PHARMA  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare SANOFI INDIA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Falling Stocks, Tumbling Rupee and Weakening Economy(Podcast)

Another week of slowdown in the markets over fears of a looming slowdown in the domestic and global economy continue.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

More Views on News

Most Popular

This 60-Year Old Smallcap Company Could Be Our Next Recommendation(The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Interest Rates Are Low. Buy Solid Dividend Stocks Instead(The 5 Minute Wrapup)

Aug 13, 2019

The dividends paid by these stocks are helpful when interest rates are falling.

Smallcaps that Will Outperform in the Market Rebound(Profit Hunter)

Aug 12, 2019

Only These Smallcaps Will Give Historic Returns in the Future.

My Top 3 Dividend Stocks to Buy Now(Profit Hunter)

Aug 19, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Chandrayaan 2 Heads to the Moon and It's Good News for These Stocks(The 5 Minute Wrapup)

Aug 14, 2019

Why investors should take note of India's advantage as a low cost satellite launcher...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Aug 23, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS